P1-45 USING THE NET MONETARY BENEFIT FRAMEWORK FOR THE OPTIMAL DICHOTOMIZATION OF DIAGNOSTIC TESTS: A CASE STUDY OF A DYSGLYCEMIA SCREENING PROGRAM,
P1-46 USING PROBABILITY ELICITATION TO PERFORM EARLY HEALTH ECONOMIC EVALUATIONS OF NEW MEDICAL PRODUCTS,
P2-57 USING STOCHASTIC MULTI-CRITERIA ACCEPTABILITY ANALYSIS TO SUPPORT DECISION MAKING ON THE REIMBURSEMENT OF MEDICAL INTERVENTIONS
P1-46 USING PROBABILITY ELICITATION TO PERFORM EARLY HEALTH ECONOMIC EVALUATIONS OF NEW MEDICAL PRODUCTS,
P2-57 USING STOCHASTIC MULTI-CRITERIA ACCEPTABILITY ANALYSIS TO SUPPORT DECISION MAKING ON THE REIMBURSEMENT OF MEDICAL INTERVENTIONS
J-4 MEASURING FAMILY HRQOL SPILLOVER EFFECTS USING DIRECT HEALTH UTILITY ASSESSMENT,
P1-5 THE ECONOMIC BURDEN OF CHILDHOOD AUTISM SPECTRUM DISORDERS,
P1-50 SIMULATING COLLATERAL WEIGHT LOSS WITHIN SOCIAL NETWORKS: CAPITALIZING ON SPILLOVER EFFECTS TO IMPROVE HEALTH,
P3-11 HOW ILLNESS AFFECTS FAMILY MEMBERS: DOMAINS OF WELL-BEING AFFECTED BY “SPILLOVER”,
P3-47 PARENT AND CHILD HEALTH UTILITIES ASSOCIATED WITH AUTISM SPECTRUM DISORDERS
P1-5 THE ECONOMIC BURDEN OF CHILDHOOD AUTISM SPECTRUM DISORDERS,
P1-50 SIMULATING COLLATERAL WEIGHT LOSS WITHIN SOCIAL NETWORKS: CAPITALIZING ON SPILLOVER EFFECTS TO IMPROVE HEALTH,
P3-11 HOW ILLNESS AFFECTS FAMILY MEMBERS: DOMAINS OF WELL-BEING AFFECTED BY “SPILLOVER”,
P3-47 PARENT AND CHILD HEALTH UTILITIES ASSOCIATED WITH AUTISM SPECTRUM DISORDERS